In October 2017 the 28th CPhI Worldwide returns to Frankfurt, Germany. This event takes place in a year where global growth across the pharmaceutical industry is flourishing. It is a particularly strong time for outsourcing & ingredients, as well as an incredibly buoyant period for the pharmaceutical manufacturing industry.
But 2017 will also be noted as an important year in development of antibody-drug conjugates.
On August 17, the U.S. Food and Drug Administration (FDA) approved inotuzumab ozogamicin (Besponsa™, Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) and only weeks later, gemtuzumab ozogamicin (Mylotarg™, previously known as CMA-676; Wyeth Pharmaceuticals, a subsidiary of Pfizer) for the treatment of adults with newly diagnosed CD33-positive acute myeloid leukemia or AML, and adults and children 2 years and older with relapsed or refractory CD33-positive AML was again approved, bringing the number of commercially available ADCs to four.
The approval of these new agents confirms the importance of antibody-drug conjugates as a class of therapeutic agents, something that is also confirmed by the increased number of proposed therapies in which antibody-drug conjugates are used as a single therapeutic agent as well as in combination with other complementary drug classes, including immune-checkpoint and DNA damage repair inhibitors is creating excitement among researchers and physicians.
There is also a renewed confidence in the North American pharma market with the three hotbeds of biotechnology – San Diego, San Francisco, and Boston – experiencing a notable resurgence.
CPhI Worldwide itself is in many ways the global barometer of the pharma industry’s overall health, and earlier this year we saw the launch of the inaugural CPhI North America. This new event, held in the world’s foremost pharma economy, represented a natural progression for the CPhI brand and was extremely successful.
But this year has seen many exciting developments throughout the globe, with the new Marketing Authorization Holder (MAH) pilot in China providing huge innovation opportunities for Chinese biotechs, and generics expanding from Japan, USA and Europe to the emerging markets. In addition, all of our global events have seen a surge in the number of bio and finished formulations attendees, again highlighting how strong these markets are.
“It’s a truly dynamic time for the global pharma industry, and CPhI Worldwide provides an opportunity to come together and focus on the latest trends, technologies and insights. Above all else, it is a platform for the industry to drive forward new partnerships, do business and grow,” said Orhan Caglayan, Brand Director Europe, UBM, the organizer of CPhI Worldwide.
CPhI Worldwide will take place on 24 – 26 October 2017 at the Messe Frankfurt, Germany. After last year’s record-breaking event, the world’s most prominent pharma executives are ready to gather again for three days of collaboration, information dissemination, and discussions that will define the future of the industry.
The 2016 CPhI Worldwide event in Barcelona saw an all-time record attendance of over 42,000 people, with 2,550+ exhibitors from 156 countries. Building on this success, CPhI Worldwide 2017 will host over 20 dedicated zones covering ingredients, APIs, excipients, contract services, packaging, biopharma, machinery, and many more.
Running concurrently with the pharmaceutical ingredients halls are four other nearby brands, helping visitors quickly identify the right event for their business’s needs:
- ICSE is an outsourcing focused event designed to connect the pharmaceutical community with contract providers from clinical trials, CROs, logistics providers, data management firms and CMOs, bringing the contract community together under one roof.
- InnoPack connects buyers and specifiers from the packaging and pharmaceutical industries, showcasing all the newest innovations in pharma packaging.
- P-MEC Europe features exhibitors from traditional large-scale capital equipment to companies focused on instrumental analysis, measuring and testing technologies, materials testing, laboratory and quality control.
- Finished Dosage Formulation for every aspect of the finished dosage supply chain, from Big Pharma and CMO to in/out-licensing and dossier specialists.
Beyond the exhibition, the Pharma Forum is CPhI’s go-to space for all pharmaceutical professionals looking to explore specialist areas and new business opportunities, as well as sourcing non-biased information on trends, innovations, developments, and the latest regulatory insights – all in one location. The Pharma Forum includes the latest innovative products and services in the Innovation Galleries, free high value content at the Pharma Insight Briefings, and the chance to share your experiences and recharge your batteries in the Insight Lounge.
CPhI is a key advocate of female executive empowerment, and on the second day of CPhI Worldwide, the Women in Leadership Forum will take place. Here, female executives will get a chance to meet and discuss with their peers about promoting diversity in the workplace. It serves as a space to share their experiences, exchange expertise, and discuss effective leadership strategies.
Pharma Insight Briefings
The CPhI Pharma Insight Briefings will offer participants the chance to access a diverse range of content through succinct 45-minute sessions. These in-depth seminars on specialist topics and regional updates will take place during the course of CPhI Worldwide. All content is free to access and open to all visitors with topics covering pharmaceutical packaging, market entry, mergers & acquisitions, mHealth, new technological developments and the latest innovations in pharmaceutical ingredients and biologics.
As well as the many free-to-attend industry seminars, the Innovation Gallery will provide a showcase for some of CPhI’s most exciting new products. This is where visitors can see innovative pharmaceutical developments in ingredients, finished dosage formulations, contract services and packaging. Moreover, a team of pharma experts will also present visitors with the opportunity for guided Innovation Tours, which run across each of the three days at CPhI Worldwide. These one-hour bespoke tours are exclusively selected by our partners to cover all sectors of the pharmaceutical industry.
Starting from the Innovation Gallery, you will travel throughout FDF, ICSE and InnoPack, garnering new perspectives and visit some of the most exciting companies at the event. Registration however, is on a first come, first served basis.
The CPhI Live Pharma Connect is your online business match and meet tool at CPhI Worldwide open to both visitors and exhibitors to pre-arrange their meetings. The system is very easy to use and automatically finds the best matches for both visitor and exhibitors needs, eliminating the need to manually search databases to find the right business connections.
CPhI Pre-connect Congress
This year’s CPhI Preconnect Congress will take place on the 23rd of October, the day prior to CPhI Worldwide, and offers its most exciting and comprehensive agenda to date. This platform gathers experts and thought leaders from the entire pharmaceutical supply chain to provide insights into the latest developments. In particular, the first keynote will feature Samsung Biologics President & CEO, Dr Tae Han Kim. He will provide an in-depth presentation addressing uncertainty in the industry, as well as the future outlook for pharma.
The second regulatory keynote will be given by Ajaz Hussain, President, National Institute for Pharmaceutical Technology & Education, Inc. & Former Deputy Director, Office for Pharmaceuticals, FDA. Mr Hussain will give a special address covering the US and European regulator’s intention to mutually recognize one another’s pharmaceutical manufacturing inspection procedure, and the urgent need to reduce regulator heterogeneity in the cGMP inspection process.
This year’s conference will also examine engaging and forward thinking topics, such as an analysis of biosimilar uptake in the US and Europe, the future of continuous processing and discussions on innovative therapies such as CRISPR, immunotherapy and personalized medicines.
Emphasizing that CPhI Worldwide is also a key opportunity to learn about new trends, business insights and prospects, the revered CPhI Annual Report launches its 5th edition. This eagerly anticipated collection of essays will provide thought leadership on the industry’s hottest topics and issues, with contributions by Ajaz Hussain, Emil Ciurczak, and Alan Sheppard amongst others, and a contract services overview from Gil Roth of the PBOA.
In recognition of pharma excellence, the vastly expanded CPhI Pharma Awards returns to the show for its 14th year, with eight new categories – awarding an impressive 20 commendations in celebration of the most successful and innovative pharma achievements. The expanded awards have been created to give wider recognition to all the great advances and technologies coming out of the pharma industry. The winners will be announced live during the prestigious CPhI Pharma Awards Gala in Frankfurt, amongst over 250 of the industry’s most important executives and luminaries.
Finally, we are striving to encourage our partners to incorporate Corporate Social Responsibility, and this CPhI Worldwide has chosen International Medical Corps UK as its official charity partner. There are a range of charity sponsorship options, with free promotions at the event and contributions going direct to International Medical Corps in order to sustain their global efforts. International Medical Corps delivers lifesaving healthcare in emergencies for people affected by disaster or conflict. They work around the clock to not only rebuild lives and communities in some of the most dangerous places on earth, but they are determined to train and pass essential skills onto local hands.
We encourage all visitors and exhibitors to consider closely our charity packages and or any other ways you might be able to help.
At the event, remember to use the official CPhI mobile app, providing exhibitors and attendees with a timetable of the day’s activities, a list of exhibitors and their hall location.
Held in the heart of Europe’s largest pharma market, this year’s event is an unmissable opportunity to network with existing contacts, and engage vital new customers that will be invaluable in moving your business to the next level.
If you have not yet registered, do so today at the CPhI Worldwide 2017 website. Free registration for CPhI Worldwide closes on the 15th October 2017.